Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-12-24
1992-02-04
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514826, A61K 3150
Patent
active
050860550
ABSTRACT:
A method of treating allergic disorders and pharmaceutical compositions therefore are disclosed for a series of 5-[(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives of Formula I. These compounds are useful in inhibiting Type I allergic ##STR1## responses in a living animal and thus can be used to treat allergic phenomena such as asthma, rhinitis, atopic dermatitis, chronic hives, allergic conjunctivitis and the like.
REFERENCES:
patent: 3419559 (1968-12-01), Lunsford et al.
patent: 3423418 (1969-01-01), Lunsford et al.
patent: 3455941 (1969-07-01), Lunsford et al.
patent: 3457267 (1969-07-01), Lunsford et al.
patent: 3513236 (1970-05-01), Lunsford et al.
patent: 4886794 (1989-12-01), Walsh
Walsh David A.
Yanni John M.
A. H. Robins Company Incorporated
Schenkman Leonard
LandOfFree
Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone deriv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-348121